Beijing Continent Pharmaceutical Co, Ltd.

This is the first study in people to test a new oral drug called F230, which is being developed to treat pulmonary hypertension—a serious condition of high blood pressure in the lungs. The main goal is to check if the drug is safe and how it moves through the body in 136 healthy …

This study is testing a new drug called F573 for people with serious liver injury or failure. It aims to see if the drug is safe and can help control liver damage. About 97 participants will receive either the drug or a placebo injection daily for up to 28 days, along with standa…

This study is testing whether a drug called pirfenidone can help people with pneumoconiosis, a serious lung disease caused by dust inhalation. Over 52 weeks, 272 patients will take either the drug or a placebo pill to see if it can slow the decline in their lung function. The goa…

This early-stage study is checking how a potential new drug for liver scarring is processed by the body and how safe it is for people with reduced kidney function. It will compare 56 participants, including healthy volunteers and people with mild to severe kidney problems, after …